Page last updated: 2024-12-07
3-chlorolactate
Description
3-Chlorolactate, also known as 2-hydroxy-3-chloropropanoate, is a synthetic compound with potential applications in various fields. It is a chiral molecule, with two enantiomers: (R)-3-chlorolactate and (S)-3-chlorolactate. The compound has been studied for its potential as a precursor for the synthesis of other valuable chemicals, including pharmaceuticals. It has been investigated for its inhibitory effects on certain enzymes, particularly those involved in carbohydrate metabolism, making it a subject of interest for research in metabolic disorders. 3-Chlorolactate has also been explored for its potential use in polymer chemistry. The study of this compound is driven by its potential applications in various fields and the desire to understand its biological effects.'
3-chlorolactate: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
3-chlorolactic acid : A 2-hydroxy monocarboxylic acid that is lactic acid in which one of the methyl hydrogens is replaced by a chloro group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 92899 |
CHEBI ID | 77855 |
SCHEMBL ID | 574040 |
MeSH ID | M0049890 |
Synonyms (41)
Synonym |
beta-chlorolactic acid, >=92.5% |
3-chlorolactate |
50906-02-0 |
AKOS003349157 |
3-chloro-2-hydroxypropanoic acid |
FT-0690330 |
unii-m4y6ua6h9u |
3-chlorolactic acid |
3-chloro-2-hydroxypropionic acid |
m4y6ua6h9u , |
propanoic acid, 3-chloro-2-hydroxy- |
einecs 216-993-0 |
beta-chlorolactic acid |
1713-85-5 |
2-hydroxy-3-chloropropionic acid |
dl-3-chlorolactic acid |
|a-chlorolactic acid |
FT-0633790 |
AKOS017259380 |
SCHEMBL574040 |
CHEBI:77855 |
propanoic acid, chloro-2-hydroxy- |
3-chloro-2-hydroxypropanoic acid # |
3-chloro-2-hydroxypropanoicacid |
74792-92-0 |
.beta.-chlorolactic acid |
(+/-)-3-chlorolactic acid |
dl-.beta.-chlorolactic acid |
3-chlorolactic acid, (+/-)- |
FT-0699410 |
mfcd00046523 |
J-010721 |
-chlorolactic acid |
Q27147463 |
AS-42289 |
DTXSID10883745 |
beta-chlorolacticacid |
EN300-85786 |
CS-0186802 |
3-chloro-2-hydroxy propanoic acid |
beta -chlorolactic acid |
Research Excerpts
Toxicity
Drug Classes (2)
Class | Description |
2-hydroxy monocarboxylic acid | |
organochlorine compound | An organochlorine compound is a compound containing at least one carbon-chlorine bond. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.83
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.83 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.14 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 1 (12.50%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |